abstract |
FIELD: medicine, pharmacy. n SUBSTANCE: invention relates to a novel drug based on anti-cholinergic agents and inhibitors of EGFR kinase, capsules containing inhalation powder and to using a drug designated for treatment of inflammatory and obstructive diseases of respiratory ways. Invention describes a novel medicinal agent useful in using in diseases of respiratory ways. n EFFECT: valuable medicinal and biochemical properties of compositions. n 32 cl, 1 dwg, 19 ex |